Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis
Non-alcoholic steatohepatitis (NASH), a cause of cirrhosis and hepatocellular carcinoma, is
characterized by fatty infiltration of the liver, inflammation, hepatocellular damage and …
characterized by fatty infiltration of the liver, inflammation, hepatocellular damage and …
Pathogenesis of nonalcoholic steatohepatitis
Nonalcoholic steatohepatitis (NASH) is a severe form of nonalcoholic fatty liver disease and
a risk factor for cirrhosis and hepatocellular carcinoma. The pathological features of NASH …
a risk factor for cirrhosis and hepatocellular carcinoma. The pathological features of NASH …
Molecular pathogenesis of NASH
A Caligiuri, A Gentilini, F Marra - International journal of molecular …, 2016 - mdpi.com
Nonalcoholic steatohepatitis (NASH) is the main cause of chronic liver disease in the
Western world and a major health problem, owing to its close association with obesity …
Western world and a major health problem, owing to its close association with obesity …
Comprehensive molecular mechanisms and clinical therapy in nonalcoholic steatohepatitis: an overview and current perspectives
M Yan, S Man, L Ma, W Gao - Metabolism, 2022 - Elsevier
Our understanding of nonalcoholic steatohepatitis (NASH) pathophysiology continues to
advance rapidly. Given the complexity of the pathogenesis of NASH, the field has moved …
advance rapidly. Given the complexity of the pathogenesis of NASH, the field has moved …
The metabolic basis of nonalcoholic steatohepatitis
MV Chakravarthy… - … , diabetes & metabolism, 2020 - Wiley Online Library
Nonalcoholic fatty liver disease (NAFLD) is a major cause of chronic liver disease and is
associated with significant morbidity and mortality worldwide, with a high incidence in …
associated with significant morbidity and mortality worldwide, with a high incidence in …
[HTML][HTML] The cellular pathways of liver fibrosis in non-alcoholic steatohepatitis
N Méndez-Sánchez, A Valencia-Rodríguez… - Annals of …, 2020 - ncbi.nlm.nih.gov
Non-alcoholic steatohepatitis (NASH) is considered the advanced stage of non-alcoholic
fatty liver disease (NAFLD). It is characterized by liver steatosis, inflammation and different …
fatty liver disease (NAFLD). It is characterized by liver steatosis, inflammation and different …
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies
G Musso, M Cassader, R Gambino - Nature reviews Drug discovery, 2016 - nature.com
Non-alcoholic fatty liver disease—the most common chronic liver disease—encompasses a
histological spectrum ranging from simple steatosis to non-alcoholic steatohepatitis (NASH) …
histological spectrum ranging from simple steatosis to non-alcoholic steatohepatitis (NASH) …
Recent insights into the pathogenesis of nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is a burgeoning health problem worldwide and an
important risk factor for both hepatic and cardiometabolic mortality. The rapidly increasing …
important risk factor for both hepatic and cardiometabolic mortality. The rapidly increasing …
Progressive liver fibrosis in non-alcoholic fatty liver disease
D Ramai, A Facciorusso, E Vigandt, B Schaf… - Cells, 2021 - mdpi.com
Non-alcoholic steatohepatitis (NASH) is a chronic and progressive form of non-alcoholic
fatty liver disease. Its global incidence is increasing and makes NASH an epidemic and a …
fatty liver disease. Its global incidence is increasing and makes NASH an epidemic and a …
[PDF][PDF] Mechanisms and disease consequences of nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is the leading chronic liver disease worldwide. Its
more advanced subtype, nonalcoholic steatohepatitis (NASH), connotes progressive liver …
more advanced subtype, nonalcoholic steatohepatitis (NASH), connotes progressive liver …